Revenue: Not disclosed in the provided data for QQ1 2025; cost of revenue: not disclosed; gross profit: not disclosed; gross profit margin: not disclosed.
Operating metrics:
- Operating income: -$95,546; YoY: +43.41%; QoQ: -190.81%
- EBITDA: -$95,546; EBITDAR: -$95,546; Operating cash flow: -$55,593
Net earnings and earnings per share:
- Net income: -$156,720; YoY: +26.85%; QoQ: -70.82%
- EPS: -$0.018; Diluted EPS: -$0.018; YoY: +53.37%; QoQ: -35.34%
Cash flow and liquidity:
- Net cash from operating activities: -$55,593; Free cash flow: -$55,593; Net change in cash: $7
- Cash at end of period: $7; Cash at beginning of period: not disclosed
Balance sheet highlights (selected):
- Total assets: $14,307; Total current assets: $14,307; Cash and cash equivalents: $7
- Total liabilities: $2,775,054; Current liabilities: $2,332,803; Short/long-term debt: Total debt $2,492,474; Long-term debt: $442,251
- Shareholders’ equity: -$2,760,747; Retained earnings: -$12,843,924
- Working capital: approximately -$2,318,496 (current assets minus current liabilities)
Observations:
- The revenue line is not disclosed, creating an incomplete top-line view. The cost and expense base (G&A $85,046; other expenses $10,500) combined with a substantial interest expense ($61,174) drove the operating loss.
- The balance sheet indicates extreme leverage and a fragile liquidity cushion, with a current ratio of approximately 0.006 and negative equity. The reported figures imply a potential inconsistency in the balance sheet data (assets vs. liabilities) that warrants verification from the latest filings. Treat the numbers as presented for analytical purposes but note data quality concerns.